PPAR-gamma(phospho-Ser273) antibody, 磷酸化Ser273过氧化酶活化增生受体γ抗体-抗体-抗体-生物在线
PPAR-gamma(phospho-Ser273) antibody, 磷酸化Ser273过氧化酶活化增生受体γ抗体

PPAR-gamma(phospho-Ser273) antibody, 磷酸化Ser273过氧化酶活化增生受体γ抗体

商家询价

产品名称: PPAR-gamma(phospho-Ser273) antibody, 磷酸化Ser273过氧化酶活化增生受体γ抗体

英文名称: PPAR-gamma(phospho-Ser273) antibody

产品编号: PR-1212P

产品价格: null

产品产地: China

品牌商标: Hopebiot

更新时间: null

使用范围: IHC,WB,ELISA,ICC,IP,IF

镇江厚普生物科技有限公司
  • 联系人 : 吴方
  • 地址 : 江苏省丹阳市吕城工业园
  • 邮编 : 212300
  • 所在区域 : 江苏省
  • 电话 : 189****1025
  • 传真 : 0511-86909515
  • 邮箱 : hopebiotech@163.com

Background:  The PPAR gamma antibody mainly is exist in the white fat organization, the fat for the PPAR gamma is born, blood sugar stability, the disease respond, the artery gruel kind hardens to rise the important function with the tumor occurrence of etc. all, but concerning the PPAR gamma to bone of function is a new research heat to order in recent years.A PPAR of many researches report gamma was go together with the body is after activate can the function promote many capable cells divided to increase to living but repress the ossification cell to divide to cause the bone measure the decrease or bone softs toward the fat cell in the marrow, the PPAR gamma promotes the ability and bones that the fat cell divide metabolize closely related, the performance is increasing along with the growth marrow fat content of the age, the ossification cell metabolism the outcome reduce, the different construction PPAR gamma 2 have the important function.

Description: Rabbit polyclonal to PPAR-gamma(phospho-Ser273)

Immunogen: A synthesized phosphopeptide derived from human PPAR-gamma around the phosphorylation site of Ser273.

Specificity:  ·Reacts with Human, Mouse, Rabbit, Pig, Dog, Cow and Rat.

·Isotype: IgG

Application:  ·Western blotting: 1/100-500. Predicted Mol wt: 58 kDa;

·Immunohistochemistry (Paraffin/frozen tissue section): 1/50-200;

·Immunocytochemistry: 1/100;

·Immunoprecipitation: 1/50;

·ELISA: 1/500;

·Optimal working dilutions must be determined by the end user.